Terms: = Testicular cancer AND ELF4, MEF, 2000, ENSG00000102034, ELFR, RP3-510O21_2, Q99607 AND Clinical Outcome
66 results:
1. Predictive and prognostic biomarkers in urological tumours.
Cimadamore A; Franzese C; Di Loreto C; Blanca A; Lopez-Beltran A; Crestani A; Giannarini G; Tan PH; Carneiro BA; El-Deiry WS; Montironi R; Cheng L
Pathology; 2024 Mar; 56(2):228-238. PubMed ID: 38199927
[TBL] [Abstract] [Full Text] [Related]
2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
3. Pan‑cancer analyses reveal the regulation and clinical outcome association of PCLAF in human tumors.
Liu X; Cheng C; Cai Y; Gu Y; Wu Y; Chen K; Wu Z
Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35425993
[TBL] [Abstract] [Full Text] [Related]
4. [Diagnosis and treatment of 21-hydroxylase deficiency with testicular adrenal rest tumors:a report of three cases and literature review].
Zhang Q; Zang L; Zhang CY; Gu WJ; Li B; Jia XF; Chen K; Pei Y; Du J; Guo QH; Ba JM; Lyu ZH; Dou JT; Mu YM
Zhonghua Nei Ke Za Zhi; 2022 Jan; 61(1):72-76. PubMed ID: 34979773
[No Abstract] [Full Text] [Related]
5. clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumor.
Blok JM; van der Poel HG; Kerst JM; Bex A; Brouwer OR; Bosch JLHR; Horenblas S; Meijer RP
World J Urol; 2021 Jun; 39(6):1969-1976. PubMed ID: 32955662
[TBL] [Abstract] [Full Text] [Related]
6. clinical outcome of post-chemotherapy retroperitoneal lymph node dissection in metastatic nonseminomatous germ cell tumour: A systematic review.
Haarsma R; Blok JM; van Putten K; Meijer RP
Eur J Surg Oncol; 2020 Jun; 46(6):999-1005. PubMed ID: 32173176
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of nuclear NF-κB, transglutaminase2, and ERCC1 as predictors of platinum resistance in testicular tumors.
Azambuja AA; Engroff P; Silva BT; Zorzetti RCS; Morrone FB
Int Braz J Urol; 2020; 46(3):353-362. PubMed ID: 32167697
[TBL] [Abstract] [Full Text] [Related]
8. Genomic Characterization of testicular Germ Cell Tumors Relapsing After Chemotherapy.
Necchi A; Bratslavsky G; Corona RJ; Chung JH; Millis SZ; Elvin JA; Vergilio JA; Suh J; Ramkissoon S; Severson E; Daniel S; Killian JK; Ali SM; Schrock AB; Reddy P; Miller VA; Welsh A; Gay LM; Ross JS
Eur Urol Focus; 2020 Jan; 6(1):122-130. PubMed ID: 30025711
[TBL] [Abstract] [Full Text] [Related]
9. clinical outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy Specimen.
Dowling CM; Assel M; Musser JE; Meeks JJ; Sjoberg DD; Bosl G; Motzer R; Bajorin D; Feldman D; Carver BS; Sheinfeld J
Urology; 2018 Apr; 114():133-138. PubMed ID: 29410311
[TBL] [Abstract] [Full Text] [Related]
10. Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors.
Mokhtech M; Rotondo RL; Bradley JA; Sandler ES; Nanda R; Logie N; Aldana PR; Morris CG; Indelicato DJ
Pediatr Blood Cancer; 2018 Jun; 65(6):e26997. PubMed ID: 29380526
[TBL] [Abstract] [Full Text] [Related]
11. Gonadal function in adult male patients with congenital adrenal hyperplasia.
Engels M; Gehrmann K; Falhammar H; Webb EA; Nordenström A; Sweep FC; Span PN; van Herwaarden AE; Rohayem J; Richter-Unruh A; Bouvattier C; Köhler B; Kortmann BB; Arlt W; Roeleveld N; Reisch N; Stikkelbroeck NMML; Claahsen-van der Grinten HL;
Eur J Endocrinol; 2018 Mar; 178(3):285-294. PubMed ID: 29339528
[TBL] [Abstract] [Full Text] [Related]
12. testicular seminoma: Are clinical features and treatment outcomes any different in India?
Anjanappa M; Kumar A; Mathews S; Joseph J; Jagathnathkrishna KM; James FV
Indian J Cancer; 2017; 54(1):385-387. PubMed ID: 29199728
[TBL] [Abstract] [Full Text] [Related]
13. testicular orphan receptor 4 promotes tumor progression and implies poor survival through AKT3 regulation in seminoma.
Chen Y; Lu J; Xia L; Xue D; Yu X; Shen D; Xu L; Li G
Cancer Sci; 2018 Feb; 109(2):384-394. PubMed ID: 29197138
[TBL] [Abstract] [Full Text] [Related]
14. [clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
[No Abstract] [Full Text] [Related]
15. Plasma Cytokines Correlated With Disease Characteristics, Progression-Free Survival, and Overall Survival in testicular Germ-Cell Tumor Patients.
Svetlovska D; Miskovska V; Cholujova D; Gronesova P; Cingelova S; Chovanec M; Sycova-Mila Z; Obertova J; Palacka P; Rajec J; Kalavska K; Usakova V; Luha J; Ondrus D; Spanik S; Mardiak J; Mego M
Clin Genitourin Cancer; 2017 Jun; 15(3):411-416.e2. PubMed ID: 28237180
[TBL] [Abstract] [Full Text] [Related]
16. Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis.
Bilen MA; Hess KR; Campbell MT; Wang J; Broaddus RR; Karam JA; Ward JF; Wood CG; Choi SL; Rao P; Zhang M; Naing A; General R; Cauley DH; Lin SH; Logothetis CJ; Pisters LL; Tu SM
Oncotarget; 2016 Dec; 7(52):86280-86289. PubMed ID: 27861143
[TBL] [Abstract] [Full Text] [Related]
17. clinical outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.
Mano R; Becerra MF; Carver BS; Bosl GJ; Motzer RJ; Bajorin DF; Feldman DR; Sheinfeld J
J Urol; 2017 Feb; 197(2):391-397. PubMed ID: 27720783
[TBL] [Abstract] [Full Text] [Related]
18. Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes.
Ortega Suero G; Sola-Valls N; Escudero D; Saiz A; Graus F
Neurologia (Engl Ed); 2018; 33(1):18-27. PubMed ID: 27460184
[TBL] [Abstract] [Full Text] [Related]
19. Pelvic Lymph Node Dissection in Patients Treated for Testis cancer: The Memorial Sloan Kettering cancer Center Experience.
Alanee SR; Carver BS; Feldman DR; Motzer RJ; Bosl GJ; Sheinfeld J
Urology; 2016 Sep; 95():128-31. PubMed ID: 27235751
[TBL] [Abstract] [Full Text] [Related]
20. Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer.
Tu SM; Bilen MA; Hess KR; Broaddus RR; Kopetz S; Wei C; Pagliaro LC; Karam JA; Ward JF; Wood CG; Rao P; Tu ZH; General R; Chen AH; Nieto YL; Yeung SC; Lin SH; Logothetis CJ; Pisters LL
Cancer; 2016 Jun; 122(12):1836-43. PubMed ID: 27018785
[TBL] [Abstract] [Full Text] [Related]
[Next]
